Health Care: Drugs

PDL BioPharma Inc (PDLI: NASDAQ)

$8.14 -0.105 | -1.27%
11/26/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 8.14
52 Week High 10.26
52 Week Low 7.22
Avg. Daily Vol. (Mil) 3.16
Beta (3 year) 0.61
Share Related Items
Mkt Cap (Mil) 1,307.72
Shares Out (Mil) 160.65
Float (Mil) 140.92
Dividend Information
Yield % 7.40
Annual Dividend 0.60
Payout Ratio 31.00
Financial Strength
Quick Ratio 1.30
Current Ratio 1.30
LT Debt/ Equity 0.68
Total Debt / Equity 1.23
Valuation Ratios
Price Earnings 4.20
Price/Sales 2.67
Price/Book 3.25
Price/Cash Flow 3.70
Per Share Data
Earnings 1.93
Sales 3.05
Book Value 2.50
Cash Flow 2.18
Business Summary
PDL BioPharma, Inc., is engaged in the discovery of a new generation of targeted treatments for cancer & immunologic diseases. It focuses on intellectual property asset management, investing in new royalty bearing assets & maximizing value of its patent.
General Information
932 Southwood Boulevard
Incline Villiage, NV 89451
www.pdl.com
Industry : Drugs
Sector: Health Care
Employees: 10
CEO: Mr. John P. Mclaughlin
Short Interest
Current Month (Mil) 36.79
Previous Month (Mil) 36.62
Short Interest Ratio (Days) 11.60
Management Effectiveness
Return on Equity 81.70
Return on Assets 33.50
Return on Investments 48.50
Profitability
Gross Margin 96.40
EBIT Margin n.a.
Profit Margin 67.10

Portfolios with PDLI

Latest PDLI Headlines from TheStreet

More Financial News for PDLI

Press Releases for PDLI

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter